Skip to main content
SpringerLink
Log in

Das „feuchte“ trockene Auge

The “wet” dry eye

  • Leitthema
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Das trockene Auge ist eine multifaktorielle Erkrankung der Tränenflüssigkeit und der Augenoberfläche, die zu Beschwerden, Sehstörungen und Tränenfilminstabilität mit möglicher Schädigung der Augenoberfläche führt. Im Wesentlichen führen zwei Mechanismen zum Bild des trockenen Auges: eine qualitative Reduktion der Tränenproduktion und eine erhöhte Verdunstung des Tränenfilms. Das evaporativ trockene Auge führt zu einer Irritation mit sekundärer Tränenhypersekretion, die dann das klinische Bild eines „feuchten Auges“ für Untersucher und Patienten zeigen kann. Die Kenntnis und das Verständnis der zugrunde liegenden Pathologien und Differenzialdiagnosen ist wichtig, um diese sehr häufige Ursache einer Epiphora z. B. von Erkrankungen der ableitenden Tränenwege abgrenzen und um eine adäquate Therapie einleiten zu können.

Abstract

Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability, with potential damage to the ocular surface. The two main causes are reduced production of aqueous tears and increased evaporation of tears. The evaporative form of dry eye results in ocular surface irritation with a secondary increase in tear production; this presents to the examiner and patient as a wet eye or epiphora. Knowledge and understanding of the basic pathologies and differential diagnoses of dry eye disease are essential to differentiate this very common form of dry eye from disorders of the lacrimal drainage system and to initiate adequate management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Anonymous (2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5:75–92

    Google Scholar 

  2. Aronowicz JD, Shine WE, Oral D et al (2006) Short term oral minocycline treatment of meibomianitis. Br J Ophthalmol 90:856–860

    Article  PubMed  CAS  Google Scholar 

  3. Avunduk AM, Avunduk MC, Varnell ED et al (2003) The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 136:593–602

    Article  PubMed  CAS  Google Scholar 

  4. Barabino S, Rolando M, Camicione P et al (2003) Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 22:97–101

    Article  PubMed  Google Scholar 

  5. Begley CG, Caffery B, Nichols KK et al (2000) Responses of contact lens wearers to a dry eye survey. Optom Vis Sci 77:40–46

    Article  PubMed  CAS  Google Scholar 

  6. Brignole F, Pisella PJ, De Saint JM et al (2001) Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 42:90–95

    PubMed  CAS  Google Scholar 

  7. Bron AJ, Tiffany JM (2004) The contribution of meibomian disease to dry eye. Ocul Surf 2:149–165

    PubMed  CAS  Google Scholar 

  8. De Paiva CS, Corrales RM, Villarreal AL et al (2006) Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 83:526–535

    Article  CAS  Google Scholar 

  9. Dougherty JM, Mcculley JP (1986) Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 27:486–491

    PubMed  CAS  Google Scholar 

  10. Dougherty JM, Mcculley JP, Silvany RE et al (1991) The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 32:2970–2975

    PubMed  CAS  Google Scholar 

  11. Doughty MJ, Fonn D, Richter D et al (1997) A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 74:624–631

    Article  PubMed  CAS  Google Scholar 

  12. Foulks GN, Bron AJ (2003) Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification and grading. Ocul Surf 1:107–126

    PubMed  Google Scholar 

  13. Geerling G, Daniels JT, Dart JK et al (2001) Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42:948–956

    PubMed  CAS  Google Scholar 

  14. Karson CN, Burns RS, Lewitt PA et al (1984) Blink rates and disorders of movement. Neurology 34:677–678

    PubMed  CAS  Google Scholar 

  15. Kunert KS, Keane-Myers AM, Spurr-Michaud S et al (2001) Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 42:2483–2489

    PubMed  CAS  Google Scholar 

  16. Lawrence MS, Redmond DE Jr (1991) MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacol Biochem Behav 38:869–874

    Article  PubMed  CAS  Google Scholar 

  17. Mathers WD, Shields WJ, Sachdev MS et al (1991) Meibomian gland morphology and tear osmolarity: changes with Accutane therapy. Cornea 10:286–290

    Article  PubMed  CAS  Google Scholar 

  18. Nakamori K, Odawara M, Nakajima T et al (1997) Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol 124:24–30

    PubMed  CAS  Google Scholar 

  19. Nichols JJ, Sinnott LT (2006) Tear film, contact lens and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci 47:1319–1328

    Article  PubMed  Google Scholar 

  20. Pflugfelder SC (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137:337–342

    Article  PubMed  Google Scholar 

  21. Pharmakakis NM, Katsimpris JM, Melachrinou MP et al (2002) Corneal complications following abuse of topical anesthetics. Eur J Ophthalmol 12:373–378

    PubMed  CAS  Google Scholar 

  22. Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418–423

    Article  PubMed  CAS  Google Scholar 

  23. Qian L, Xie J, Rose CM et al (2004) Altered traffic to the lysosome in an ex vivo lacrimal acinar cell model for chronic muscarinic receptor stimulation. Exp Eye Res 79:665–675

    Article  PubMed  CAS  Google Scholar 

  24. Rolando M, Refojo MF, Kenyon KR (1985) Tear water evaporation and eye surface diseases. Ophthalmologica 190:147–149

    Article  PubMed  CAS  Google Scholar 

  25. Shine WE, Mcculley JP (1991) The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci 32:2272–2280

    PubMed  CAS  Google Scholar 

  26. Shine WE, Silvany R, Mcculley JP (1993) Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci 34:2291–2296

    PubMed  CAS  Google Scholar 

  27. Sommer A, Emran N (1982) Tear production in vitamin A-responsive xerophthalmia. Am J Ophthalmol 93:84–87

    PubMed  CAS  Google Scholar 

  28. Tamargo RJ, Bok RA, Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51:672–675

    PubMed  CAS  Google Scholar 

  29. Tang NE, Zuure PL, Pardo RD et al (2000) Reflex lacrimation in patients with glaucoma and healthy control subjects by fluorophotometry. Invest Ophthalmol Vis Sci 41:709–714

    PubMed  CAS  Google Scholar 

  30. Turner K, Pflugfelder SC, Ji Z et al (2000) Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 19:492–496

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Universitäts-Augenklinik Würzburg, Josef -Schneider -Straße 11, 97080, Würzburg, Deutschland

    M. Schargus &  G. Geerling

Authors
  1. M. Schargus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Geerling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Geerling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schargus, M., Geerling, G. Das „feuchte“ trockene Auge. Ophthalmologe 106, 235–241 (2009). https://doi.org/10.1007/s00347-008-1908-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-008-1908-7

Schlüsselwörter

Keywords

Search

Navigation